Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials

• Autors principals: Gisella Figlioli (Autor), Daniele Piovani (Autor), Spyros Peppas (Autor), Nicola Pugliese (Autor), Cesare Hassan (Autor), Alessandro Repici (Autor), Ana Lleo (Autor), Alessio Aghemo (Autor), Stefanos Bonovas (Autor)
• Format: Llibre
• Publicat: Elsevier, 2024-10-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly used for glucose lowering and weight-loss. However, their association with gastrointestinal cancer remains uncertain. This meta-analysis assesses the risk of gastrointestinal cancer in patients treated with GLP-1 RAs. Met...